The colorado thyroid disease prevalence study

Archives of Internal Medicine

Volumn 160, Issue 4, 2000, Pages 526-534

  Canaris, Gay J ^a,e   Manowitz, Neil R ^b   Mayor, Gilbert ^b,d   Ridgway, E Chester ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b ABBOTT LABORATORIES   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d Mayor Group LLC   (United States)

^e NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; THYROID DISEASE; THYROID FUNCTION;

EID: 0034723754     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.4.526     Document Type: Article

References (52)

1. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977;7:481-493.
2. Vanderpump MPJ, Tunbridge WMG. The epidemiology of thyroid disease. In: Braverman LE, Utiger RD, eds. The Thyroid. 9th ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1996:474-482.
3. Eggersten R, Petersen K, Lundberg PA, Nystrom E, Lindstedt G. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. BMJ. 1988;297:1586-1592.
4. Sawin CT, Chopra D, Azizi F, Mannix JE, Bacharach P. The aging thyroid: increased prevalence of serum thyrotropin levels in the elderly. JAMA. 1979;242: 247-250.
5. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid: thyroid deficiency in the Framingham study. Arch Intern Med. 1985;145: 1386-1388.
6. Okamura K, Ueda K, Sone H, et al. A sensitive thyroid stimulating hormone assay for screening of thyroid functional disorder in elderly Japanese. J Am Geriatr Soc. 1989;37:317-322.
7. Livingston EH, Hershman JM, Sawin CT, Yoshikawa TT. Prevalence of thyroid disease and abnormal thyroid tests in older hospitalized and ambulatory persons. J Am Geriatr Soc. 1987;35:109-114.
8. Roti E, Montermini M, Robuschi G, et al. Prevalence of hypothyroidism and Hashimoto's thyroiditis in two elderly populations with different dietary iodine intake. In: Pinchera A, Ingbar SH, McKenzie J, Fenzis GF, eds. Thyroid Autoimmunity. New York, NY: Plenum Press; 1987:555-557.
9. Ross DS, Neer RM, Ridgway EC, Daniels GH. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitarythyroid axis with L-thyroxine. Am J Med. 1987;82:1167-1170.
10. Paul TL, Kerrigan J, Kelly AM, Braverman LE, Baran DT. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA. 1988;259:3137-3141.
11. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249-1252.
12. Biondi B, Fazio S, Carella C, et al. Cardiac effects of long term thyrotropinsuppressive therapy with levothyroxine. J Clin Endocrinol Metab. 1993;77:334-338.
13. Lithell H, Boberg J, Hellsing K, et al. Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy. Eur J Clin Invest. February 1981; 11:3-10.
14. Friis T, Pedersen LR. Serum lipids in hyper and hypothyroidism before and after treatment. Clin Chim Acta. 1987;162:155-163.
15. Series JJ, Biggart EM, O'Reilly DS, Packard CJ, Shepard J. Thyroid dysfunction and hypercholesterolemia in the general population of Glasgow, Scotland. Clin Chim Acta. 1988;172:217-222.
16. Ballantyne FC, Epenetos AA, Caslake M, Forsythe S, Ballantyne D. The composition of low-density lipoprotein and very-low-density lipoprotein subfractions in primary hypothyroidism and the effect of hormone-replacement therapy. Clin Sci (Colch). 1979;57:83-88.
17. Kuusi T, Taskinen MR, Nikkila EA. Lipoproteins, lipolytic enzymes. and hormonal status in hypothyroid women at different levels of substitution. J Clin Endocrinol Metab. 1988;66:51-56.
18. Kutty KM, Bryant DG, Farid NR. Serum lipids in hypothyroidism: a re-evaluation. J Clin Endocrinol Metab. 1978;46:55-56.
19. Valdemarsson S, Hansson P, Hedner P, Nilsson-Ehle P. Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations. Acta Endocrinol. 1983;104:50-56.
20. Elder J, McLelland A, O'Reilly DS, Packard CJ, Series JJ, Shepard J. The relationship between serum cholesterol and serum thyrotropin, thyroxine and triiodothyronine concentrations in suspected hypothyroidism. Ann Clin Biochem. 1990;27:110-113.
21. Pazos F, Alvarez JJ, Rubies-Prat J, Varela C, Lasuncion MA. Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins. J Clin Endocrinol Metab. 1995;80:562-566.
22. Franklyn JA, Daykin J, Betteridge J, et al. Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol. 1993;38:453-459.
23. Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med. 1992;92:631-642.
24. Althaus BU, Staub JJ, Ryff de Leche A, Oberhansli A, Stahelin HB. LDL/HDL changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol. 1988;28:157-163.
25. Arem R, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism: effect of levothyroxine therapy. Arch Intern Med. 1990;150:2097-2100.
26. Arem R, Escalante DA, Arem N, Morisett JD, Patsch W. Effect of L-thyroxine therapy in overt and subclinical hypothyroidism, with special reference to lipoprotein(a). Metabolism. 1995;44:1559-1563.
27. Garber AM, Browner WS, Hulley SB. Clinical guideline, part 2: cholesterol screening in asymptomatic adults, revisited. Ann Intern Med. 1996;124:518-531.
28. Bogner U, Arntz HR, Peters H, Schleusener H. Subclinical hypothyroidism and hyperlipoproteinemia: indiscriminate L-thyroxine treatment not justified. Acta Endocrinol. 1993;128:202-206.
29. Tunbridge WMG, Evered DC, Hall R, et al. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf). 1977;7:495-508.
30. Caron P, Calazel C, Parra HJ, Hoff M, Louvet JP. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol (Oxf). 1990;33:519-523.
31. Gavin LA. The diagnostic dilemmas of hyperthyroxinemia and hypothyroxinemia. Adv Intern Med. 1988;33:185-203.
32. Larsen PR, Ingbar SH. The thyroid gland. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. 8th ed. Philadelphia, Pa: WB Saunders Co; 1992: 357-487.
33. Schectman JM, Kallenberg GA, Shumacher RJ, Hirsch RP. Yield of hypothyroidism in symptomatic primary care patients. Arch Intern Med. 1989;149: 861-864.
34. Canaris GJ, Steiner JF, Ridgway EC. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med. 1997;12:544-550.
35. Billewicz WZ, Chapman RS, Crooks J, et al. Statistical methods applied to the diagnosis of hypothyroidism. QJM. 1969;38:255-266.
36. Seshadri MS, Samuel BU, Kanagasabapathy AS, Cherian AM. Clinical scoring system for hypothyroidism: is it useful? J Gen Intern Med. 1989;4:490-492.
37. White GH, Walmsley RN. Can the initial clinical assessment of thyroid function be improved? Lancet. 1978;2:933-935.
38. Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med. 1990;112: 840-849.
39. Zulewski H, Muller B, Exer P, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab. 1997;82:771-776.
40. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-Thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med. July 1984;101:18-24.
41. Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg PA, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with "subclinical" hypothyroidism. Clin Endocrinol. 1988;29:63-76.
42. Biondi B, Fazio S, Carella C, et al. Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab. 1994;78:1028-1033.
43. Spencer CA, LoPresti JS, Patel A, et al. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab. 1990; 70:453-460.
44. Adler JJ, Bloss CM Jr, Mosley KT. The Oklahoma State Department of Health Mobile Multiphasic Screening Program for Chronic Disease, I. Am J Public Health Nations Health. 1966;56:918-925.
45. Bletzer KV. Review of a health fair screening program in mid-Michigan. J Community Health. 1989;14:149-157.
46. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol. 1991;34:77-83.
47. Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA. 1987;258:209-213.
48. Ross DS, Daniels GH, Gouveia D. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an outpatient endocrine clinic. J Clin Endocrinol Metab. 1990;71:764-769.
49. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 1986;2:933-936.
50. Lipid Research Clinics Coronary Primary Prevention Trial results, I: reduction in incidence of coronary heart disease. JAMA. 1984;251:351-364.
51. The Lipid Research Clinics Coronary Primary Prevention Trial results, II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365-374.
52. Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA. 1996;276:285-292.